Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
grade of the MA-degree, the diploma must be handed in no later than June 9th 2026). The deadline for submission is April 7th 2026. Dissertation projects are supervised by faculty members of the Department
-
Your position A fully funded PhD position is available in the Computational Pharmacy group at the University of Basel. The successful candidate will contribute to ongoing research on the development
-
Science (with Prof. Denise Traber) for a duration of four years. This position is for an initial period of one years, renewable for another three years after positive evaluation. The starting date
-
Your position This project examines the quality of politicians, with a particular focus on how citizens assess it. Beyond ideology, we explore whether MPs can effectively perform and implement
-
. Specifically, it comprises: Supporting the development of flipped classroom courses (e.g., for the Pathways to Sustainability course program); Conducting a market analysis of existing courses in the field
-
the University of Basel. Specifically, it comprises: Supporting the development of flipped classroom courses (e.g., for the Pathways to Sustainability course program); Conducting a market analysis of existing
-
The Swiss Tropical and Public Health Institute (Swiss TPH) is a world-leading institute in global health with a particular focus on low- and middle-income countries. Associated with the University
-
The Department of Biomedical Engineering (DBE) at the University of Basel is a joint venture between the University of Basel, the University Hospital Basel, and the University Children's Hospital
-
, the candidate should be committed to: doing field work, wet-lab work, learning about bioinformatics, including R and shell programing, and analyzing data using population genetics tools and theories
-
The National Center of Competence in Research (NCCR) AntiResist is a Swiss-wide research consortium funded by the Swiss National Science Foundation (SNSF). AntiResist is transforming antibiotic